eRoundup for 09/23/11
Atlanta Clinical & Translational
September 23, 2011
Community Engagement Mini-Grant RFA-LOI Due September 26
The ACTSI’s Community Engagement & Research Program’s Mini-Grant Program invites proposals for partnership-based health projects that involve collaborations between a community organization and a faculty member affiliated with Morehouse School of Medicine, Emory University, or Georgia Institute of Technology. Health topics may include, but need not be limited to, cancer, diabetes, heart disease, HIV/AIDS/other STDs, nutrition, physical activity, stroke, teen pregnancy, tobacco, or violence/injury. A technical conference call will be held on October 4 at 10:00 a.m.
Healthcare Innovation Program/ACTSI Seed Grant RFP-Due October 15
The Emory/Georgia Tech Healthcare Innovation Program (HIP), in partnership with the ACTSI, is pleased to invite research seed grant proposals in Healthcare Innovation. The seed grant program will fund multi-investigator, multidisciplinary teams examining healthcare services and clinical effectiveness. Awards will support innovative approaches that address issues of healthcare quality, costs, and/or access that are consistent with the goals of the HIP and the ACTSI. Preliminary Study grants and Complete Project grants will be offered. More information is available here.
Emory-Egleston Children's Research Center Seed Grant RFA-Due October 17
The Emory-Egleston Children’s Research Center announces the 2012 Seed Grant Program. The program provides funding for projects in basic, translational and clinical research with goals of understanding the mechanisms and potential treatments for diseases of children. Questions?
Request for Proposals for Young Investigators New to HIV/AIDS Research-Concept Proposal Due October 17
National CFARs, the Office of AIDS Research and the International AIDS Society are pleased to announce an opportunity to submit proposals for the CNIHR-Creative and Novel Ideas in HIV Research program. This research grant program is for early career investigators with no prior experience in HIV research.
Director's Transformative Research Projects Awards-LOI Due December 12
Funding opportunity for exceptionally innovative, high risk, original and/or unconventional research and clinical, basic, and/or behavioral/social science research projects. Up to $25 million total costs per year for a single project. Informational webinar on Tuesday, from 1:00-2:45 p.m.
The Future of Nursing: Leading Change, Advancing Health: Recommendations Funded by Robert Wood Johnson Foundation-Due January 3
The Robert Wood Johnson Foundation (RWJF) is coordinating an initiative to identify, generate, synthesize and disseminate evidence essential to informing efforts to implement the recommendations outlined in the Institute of Medicine report, The Future of Nursing: Leading Change, Advancing Health. The purpose of this activity is to facilitate and coordinate funding activity across a range of funders of nursing research. From now until January 3, 2012, RWJF will accept proposals that address the research priorities listed in this document.
Dr. Rani Singh
Health Systems Institute
The Georgia Tech/Emory University Health Systems Institute (HIS) was created in 2005 as a multi-institutional and interdisciplinary initiative. HSI brings together the expertise of many disciplines at Georgia Tech and Emory to enable the development and implementation of novel collaborative research, education and outreach programs. The goal is to transform healthcare delivery systems and lead the nation away from an ineffective, reactive, disease-focused system to achieve a cost-effective, pro-active, health and wellness-focused system.
CTSA Public-Private Partnerships Webinar Series-September 28
A New Paradigm for Pharmaceutical Innovation will be led by Tufts University’s Kenneth Kaitin from 3:00-4:00 p.m. Sponsored by Tufts Center for the Study of Drug Development, featuring analysis on R&D trends and patent information on the 10 top companies and drugs. Webinar Link
Why Our Proteins Have to Die So We Shall Live?-October 3
Presented by Nobel Laureate Aaron Ciechanchover, MD, DSc of the Israel Institute of Technology, from noon – 1:00 p.m. in Emory’s Winship Cancer Institute (1365 Clifton Rd, 30322), Room C5012. Dr. Ciechanchover will present the Ubiquitin Proteolytic System, from basic mechanism through human diseases and onto drug development. Sponsored by – Department of Pediatrics, Emory University School of Medicine, Georgia Institute of Technology, The Emory Graduate Program, The Department of Veterans Affairs and the Center for AIDS Research (CFAR).
Holocaust/Twin Experiment Survivor: Forgiving the Unforgivable-October 4 & 5
Eva Mozes Kor, an identical twin who survived the Holocaust and the macabre experiments of Dr. Josef Mengele, will speak about her experience at Auschwitz and lead an interactive discussion on the concept of forgiveness. She will use this narrative to draw lessons for today’s research community and public-at-large based in the concept of mutual respect and justice. Three presentations: October 4, at 7:00 p.m. in Glenn Memorial Church (1660 N Decatur Rd) Room 102; October 5, at Noon in Emory’s Harland Cinema Theater; and from 5:30-8:30 p.m. a buffet dinner, networking, book signing, speaker discussion will be held in the Carlos Museum at Emory (third floor Reception Hall) and is co-sponsored by the Atlanta Chapter of the Association of Clinical Research Professionals.
Research Administrators Certification Council Body of Knowledge Review Session-November 12
The Research Administrators Certification Council (RACC) visits Emory from 8:30 a.m. until 5:30 p.m. to present their Body of Knowledge Review Session in the Jones Room of the Robert W. Woodruff Library. Email firstname.lastname@example.org for more information.
France-Atlanta 2011 Presents Scientific Symposia on Kidney Disease and Transplantation-November 3
French and American scientists, academics and experts in kidney transplantation will gather to participate in the one-day symposia, Translational Treatments: Advances in Renal Transplantation, at 8:00 a.m. at the Emory Transplant Center. French and American immunologists and transplant physicians will address critical topics on the care of renal transplant patients. Distinguished research scholars, such as Dr. Christophe Legendre (Necker Hospital), Dr. Lionel Rostaing (Rangueil-Toulouse Hospital), Dr. Jean-Paul Soulillou (Nantes Hospital), Dr. Antonio Guasch and ACTSI investigator Dr. Thomas Pearson (Emory School of Medicine), will give presentations, share ideas, and exchange best practices in the diagnosis and management of patients.
Emory Alzheimer's Disease Research Center Scientific Retreat-November 5
The Emory Alzheimer's Disease Research Center hosts a scientific retreat from 8:00 a.m.-4:00 p.m. in the Emory School of Medicine Conference Room 130. The focus of the retreat is Risk Factors and Early Detection of Alzheimer's Disease (AD) as well as Norepinephrine and Inflammation in AD. There is no charge for the retreat and individuals can register by email.
FDA Regulatory Training Opportunity for ACTSI Clinical Investigators-November 7-9
The third annual FDA Clinical Investigator Training Course, co-sponsored by the FDA’s Office of Critical Path Programs and the Clinical Trials Transformation Initiative (CTTI), is now open for registration. The course will be held at the National Labor College in Silver Spring, MD. This intensive, three-day course will enable clinical investigators to gain a greater appreciation of the scientific, ethical and regulatory issues relating to clinical trial data that may be submitted to regulatory bodies.
White House Statement on Patent Reform and NCATS
The White House issued a statement this week after patent reform was signed into law. The new law has implications for operations of university tech transfer and licensing offices and research leaders. The President used the occasion to describe other Federal initiatives to R&D and commercialization of technology, including a statement on launching NIH’s National Center for Advancing Translational Sciences (NCATS). The center will assist biotech entrepreneurs and move ideas from lab to market and be the new NIH home of the CTSA. To help industry shorten the time needed and reduce costs for the development of new drugs and diagnostics, the NIH plans to establish NCATS. The center aims to help biomedical entrepreneurs by identifying barriers to progress and providing science-based solutions to reduce costs and the time required to develop new drugs and diagnostics.
ACTSI Investigator Dr. Miriam Vos in the News
Miriam Vos, MD, MSPH, ACTSI investigator, assistant professor of pediatrics in the Emory University School of Medicine, and a physician on staff at Children’s Healthcare of Atlanta
Institute for People and Technology 2011-12 Georgia Tech – Children’s Healthcare of Atlanta Pilot Grants Program
Virtual Reality Technology as a Treatment for Overweight Children with NAFLD – Miriam Vos
2011 Emory+Children’s Pediatric Research Center’s Center for Clinical Outcomes Research & Public Health pilot award recipient
Impact of maternal and child trauma on metabolic risk factors in children – Miriam Vos
Emory Health Now Blog | Americans cutting sugar – but it’s still not enough
August 15, 2011
Emory Health Now Blog | Emory experts weigh in on obesity at AACC Annual Meeting
August 3, 2011
Los Angeles Times | We're eating less sugar -- but still far too much
July 30, 2011
Food Consumer | Eating fructose linked to high risk of fatty liver disease?
June 29, 2011
Dr. Oz Show | Dr. Oz: Sugar: The #1 food you need to lose
January 20, 2011